Amplia Therapeutics Limited (INNMF)
USD 0.06
(0.0%)
USD 0.06
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -4.5 Million AUD | 27.86% |
| 2023 | -6.24 Million AUD | -71.3% |
| 2022 | -3.64 Million AUD | -59.76% |
| 2021 | -2.28 Million AUD | -2.79% |
| 2020 | -2.21 Million AUD | -18.66% |
| 2019 | -1.87 Million AUD | 56.49% |
| 2018 | -4.29 Million AUD | 39.26% |
| 2017 | -7.07 Million AUD | -43.15% |
| 2016 | -4.94 Million AUD | 5.61% |
| 2015 | -5.23 Million AUD | -16.51% |
| 2014 | -4.49 Million AUD | 0.0% |
| 2013 | - AUD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -1.12 Million AUD | -100.0% |
| 2024 FY | -4.5 Million AUD | 27.86% |
| 2024 Q1 | -564.62 Thousand AUD | 83.05% |
| 2024 Q4 | -3.37 Million AUD | 0.0% |
| 2023 FY | -6.24 Million AUD | -71.3% |
| 2023 Q2 | -2.91 Million AUD | -100.0% |
| 2023 Q3 | -1.66 Million AUD | 42.81% |
| 2023 Q4 | -3.33 Million AUD | -100.0% |
| 2023 Q1 | -1.45 Million AUD | 37.29% |
| 2022 Q4 | -2.32 Million AUD | 0.0% |
| 2022 FY | -3.64 Million AUD | -59.76% |
| 2022 Q2 | -1.32 Million AUD | 0.0% |
| 2021 Q4 | -1.76 Million AUD | 0.0% |
| 2021 Q2 | -511.21 Thousand AUD | 0.0% |
| 2021 FY | -2.28 Million AUD | -2.79% |
| 2020 Q4 | -1.33 Million AUD | 0.0% |
| 2020 FY | -2.21 Million AUD | -18.66% |
| 2020 Q2 | -885.26 Thousand AUD | 0.0% |
| 2019 FY | -1.87 Million AUD | 56.49% |
| 2018 FY | -4.29 Million AUD | 39.26% |
| 2017 FY | -7.07 Million AUD | -43.15% |
| 2016 FY | -4.94 Million AUD | 5.61% |
| 2015 FY | -5.23 Million AUD | -16.51% |
| 2014 FY | -4.49 Million AUD | 0.0% |
| 2013 FY | - AUD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -74.96 Million USD | 93.992% |
| Nanobac Pharmaceuticals, Incorporated | -6.57 Million USD | 31.518% |
| SQZ Biotechnologies Company | -79.46 Million USD | 94.333% |
| Evofem Biosciences, Inc. | 52.97 Million USD | 108.5% |
| Santhera Pharmaceuticals Holding AG | 65.13 Million USD | 106.914% |
| Mesoblast Limited | -87.95 Million USD | 94.88% |
| Propanc Biopharma, Inc. | -1.82 Million USD | -147.371% |
| Genus plc | 7.9 Million USD | 157.006% |
| VioQuest Pharmaceuticals, Inc. | -10.89 Million USD | 58.653% |
| CNBX Pharmaceuticals Inc. | -3.71 Million USD | -21.379% |
| Marizyme, Inc. | -65.34 Million USD | 93.108% |
| ContraFect Corporation | -65.15 Million USD | 93.088% |
| Nymox Pharmaceutical Corporation | -8.84 Million USD | 49.079% |
| PsyBio Therapeutics Corp. | -4.88 Million USD | 7.831% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.72 Million USD | -160.699% |
| Intellipharmaceutics International Inc. | -2.89 Million USD | -55.7% |
| AXIM Biotechnologies, Inc. | -8.05 Million USD | 44.124% |
| MultiCell Technologies, Inc. | -380.07 USD | -1184800.939% |
| Accustem Sciences Inc. | -3.74 Million USD | -20.207% |
| RVL Pharmaceuticals plc | -51.69 Million USD | 91.288% |
| EV Biologics, Inc. | -1.26 Million USD | -255.405% |
| Q BioMed Inc. | -2.05 Million USD | -119.457% |
| Emmaus Life Sciences, Inc. | -3.73 Million USD | -20.639% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -612.113% |
| Mosaic ImmunoEngineering Inc. | -2.38 Million USD | -89.152% |
| Biomind Labs Inc. | -1.21 Million USD | -270.862% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | -10.54 Million USD | 57.305% |
| Oncotelic Therapeutics, Inc. | -7.9 Million USD | 43.017% |
| Skye Bioscience, Inc. | -37.64 Million USD | 88.037% |
| Therapeutic Solutions International, Inc. | -2.16 Million USD | -107.55% |
| THC Farmaceuticals, Inc. | -14.97 Thousand USD | -29971.134% |
| Arch Therapeutics, Inc. | -6.98 Million USD | 35.507% |
| IMV Inc. | -36.48 Million USD | 87.657% |
| Acro Biomedical Co., Ltd. | -15.87 Million USD | 71.625% |
| Curative Biotechnology, Inc. | -5.81 Million USD | 22.585% |
| GB Sciences, Inc. | -1.36 Million USD | -230.728% |
| Alpha Cognition Inc. | -13.77 Million USD | 67.301% |
| HST Global, Inc. | -146.21 Thousand USD | -2980.127% |
| CSL Limited | 2.64 Billion USD | 100.17% |
| Halberd Corporation | -79.67 Thousand USD | -5552.208% |
| Enzolytics Inc. | -2.17 Million USD | -106.881% |
| Resverlogix Corp. | -3.61 Million USD | -24.749% |
| Affymax, Inc. | -14.42 Million USD | 68.778% |
| SYBLEU INC | -180.3 Thousand USD | -2397.7% |
| Nuo Therapeutics, Inc. | -3.17 Million USD | -42.0% |
| argenx SE | -295.05 Million USD | 98.474% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -62.59 Million USD | 92.806% |
| Enzon Pharmaceuticals, Inc. | 98 Thousand USD | 4695.36% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -3.97 Million USD | -13.352% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.02 Million USD | -48.819% |
| AVAX Technologies, Inc. | -6.41 Million USD | 29.783% |
| Zenith Capital Corp. | -10.59 Million USD | 57.499% |
| Genscript Biotech Corporation | -95.47 Million USD | 95.283% |
| Ember Therapeutics, Inc. | -23.24 Thousand USD | -19276.357% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -4.14 Million USD | -8.623% |
| WPD Pharmaceuticals Inc. | -60.44 Thousand USD | -7351.038% |
| American Oriental Bioengineering, Inc. | -59.72 Million USD | 92.46% |
| Provectus Biopharmaceuticals, Inc. | -3.1 Million USD | -45.19% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -1.05 Million USD | -326.44% |
| GlobeStar Therapeutics Corporation | -1.94 Million USD | -131.035% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -3.81 Million USD | -17.922% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -124.598% |
| BioStem Technologies, Inc. | -8.48 Million USD | 46.912% |
| ONE Bio Corp. | 8.67 Million USD | 151.903% |
| Reve Technologies, Inc. | -441.36 Thousand USD | -920.337% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -237.228% |
| Wesana Health Holdings Inc. | -1.75 Million USD | -156.64% |
| Agentix Corp. | -1.37 Million USD | -227.712% |
| LadRx Corporation | 400.44 Thousand USD | 1224.618% |
| Cell Source, Inc. | -5.32 Million USD | 15.368% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -983.918% |
| Regen BioPharma, Inc. | 1.02 Million USD | 540.002% |
| Regen BioPharma, Inc. | 1.02 Million USD | 540.002% |
| NovAccess Global Inc. | -4.76 Million USD | 5.572% |
| Endonovo Therapeutics, Inc. | 6.92 Million USD | 165.036% |
| Itoco Inc. | -1.86 Million USD | -140.956% |
| Rasna Therapeutics, Inc. | -4.44 Million USD | -1.371% |
| Pathfinder Cell Therapy, Inc. | -1.66 Million USD | -169.829% |
| Kadimastem Ltd | -3.3 Million USD | -36.163% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -273.4 Thousand USD | -1547.191% |
| CytoDyn Inc. | -49.84 Million USD | 90.964% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.03 Thousand USD | -5598.193% |
| Mobile Lads Corp. | -2.26 Million USD | -98.978% |
| NanoSphere Health Sciences Inc. | -228.12 Thousand USD | -1874.099% |
| Qrons Inc. | -789.34 Thousand USD | -470.529% |
| Alseres Pharmaceuticals, Inc. | -941.52 Thousand USD | -378.313% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -2.08 Million USD | -115.715% |
| Rebus Holdings, Inc. | -1.02 Million USD | -341.515% |
| ImmunoCellular Therapeutics, Ltd. | -1.61 Million USD | -179.243% |
| International Stem Cell Corporation | -131 Thousand USD | -3337.75% |
| Bioxytran, Inc. | -4.28 Million USD | -5.221% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -54.27 Thousand USD | -8197.931% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.53 Million USD | -77.985% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -48.07 Million USD | 90.632% |
| Adhera Therapeutics, Inc. | -2.11 Million USD | -113.03% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -780.88 Thousand USD | -476.71% |
| Innovation Pharmaceuticals Inc. | -3.16 Million USD | -42.154% |
| Neutra Corp. | -233.46 Thousand USD | -1828.963% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | 77.806% |
| PureTech Health plc | -65.69 Million USD | 93.145% |
| Coeptis Therapeutics, Inc. | -21.26 Million USD | 78.824% |
| IXICO plc | -1.17 Million USD | -282.297% |
| IntelGenx Technologies Corp. | -9.92 Million USD | 54.634% |
| Gelesis Holdings, Inc. | -57.12 Million USD | 92.117% |
| CSL Limited | 2.64 Billion USD | 100.17% |
| Cellectis S.A. | -103.17 Million USD | 95.635% |